Small Molecule Videos

  1. SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance 3/11/2026

    Join Frank Mueller, Executive Director of Business Development, for an overview of our capabilities and global capacity spanning North America, Europe, and Asia.

  2. Novartis Capabilities Update March 2026: Small Molecule Drug Substance 3/11/2026

    Driven by a strong commitment to quality, compliance, and operational excellence, our teams deliver reliable and scalable manufacturing solutions tailored to each partner’s unique requirements.

  3. From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development 3/8/2026

    See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

  4. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

  5. Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development 3/2/2026

    Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.

  6. Grace Capabilities Update February 2026: AI Drug Development 3/2/2026

    Discover support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.

  7. Re-Thinking ASD Development: When Your Molecule Breaks The Rules 2/26/2026

    A solvent‑free, fusion‑based approach streamlines amorphous solid dispersion development, enabling rapid early screening, improved performance, and sustainable manufacturing.

  8. From Brick Dust To Breakthrough: The Power Of Enabled Formulation 2/26/2026

    Enabled formulation strategies transform poorly soluble, highly lipophilic molecules into viable oral products by improving exposure, reducing burden, and ensuring manufacturable pathways.

  9. From Molecule To Milestone: Fast Track Formulation 2/26/2026

    Fast‑track, data‑driven formulation strategies align early decisions with long‑term goals, enabling First‑in‑Human progress while reducing risk, avoiding rework, and supporting manufacturable development.

  10. Navigating Complexity: Tailored Analytical & Preclinical Services 2/26/2026

    Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.